These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1210909)

  • 1. [Toxin B and A production by beta-hemolytic streptococci isolated from scarlet fever patients].
    Cherkasskaia RS; Dodonov VN; Gladkova KK; Silich VA; Fiks LI
    Zh Mikrobiol Epidemiol Immunobiol; 1975 May; (5):53-7. PubMed ID: 1210909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Toxigenic hemolytic streptococci isolated from patients with scarlatina and those having contact with them].
    Cherkasskaia RS; Dodonov VN; Silich VA; Gladkova KK; Fiks LI
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):67-72. PubMed ID: 4273361
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of the antibody neutralization reaction for the characteristics of toxigenicity of hemolytic streptococci].
    Silich VA; Cherkasskaia RS; Fiks LI
    Lab Delo; 1973; 11():674-8. PubMed ID: 4132573
    [No Abstract]   [Full Text] [Related]  

  • 4. STUDIES ON THE BIOLOGY OF STREPTOCOCCUS : II. ANTIGENIC RELATIONSHIPS BETWEEN STRAINS OF STREPTOCOCCUS HAEMOLYTICUS ISOLATED FROM SCARLET FEVER.
    Bliss WP
    J Exp Med; 1922 Oct; 36(5):575-605. PubMed ID: 19868695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Virulent and toxigenic properties of beta-hemolytic streptococci in relation to the scarlatina epidemic process].
    Gladkova KK; Dodonov VN; Bliumental' KV; Cherkasskaia RS; Severov AM
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jul; 50(7):24-7. PubMed ID: 4272990
    [No Abstract]   [Full Text] [Related]  

  • 6. Some characteristics of nontypable group A streptococci.
    Quinn RW; Lowry PN
    Yale J Biol Med; 1972 Dec; 45(6):572-83. PubMed ID: 4655808
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of typing beta-hemolytic streptococci from patients with scarlet fever].
    Adanja B; Vlajinac H; Canić M
    Vojnosanit Pregl; 1979; 36(3):199-202. PubMed ID: 506140
    [No Abstract]   [Full Text] [Related]  

  • 8. [Incidence of hemolytic streptococci in throat-swabs of normal persons, persons with scarlet fever and persons who live in scarlet fever or streptococcal environment].
    FISCHER A
    Arztl Wochensch; 1956 Mar; 11(8-9):192-5. PubMed ID: 13326724
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphocyte-stimulating activity of scarlet fever toxin.
    Hríbalová V; Pospísil M
    Experientia; 1973 Jun; 29(6):704-5. PubMed ID: 4578079
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the toxin and toxoid of hemolytic streptococci.
    KODAMA T; SUZUKI T; MORIKUBO S
    Kitasato Arch Exp Med; 1950 Jul; 23(1):39-44. PubMed ID: 14774995
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibodies to erythrogenic toxin B in scarlatina patients].
    Silich VA; Fiks LI; Dodonov VN; Sezonova EP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):112-5. PubMed ID: 1092101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Typing of beta-hemolytic streptococci by hemagglutination test].
    Manabe S; Kudo I; Higashi T
    Kumamoto Igakkai Zasshi; 1970 Mar; 44(3):230-4. PubMed ID: 4914093
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics of beta-hemolytic streptococci secreted in children in various climatic zones].
    Gladkova KK; Cherkasskaia RS; Dodonov VN; Severov AM; Silich VA
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Dec; (12):71-4. PubMed ID: 130040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A method for selective detection of hemolytic streptococci in scarlet fever as well as observations in simultaneous anaerobic culture].
    GIERHAKE FW
    Klin Wochenschr; 1954 Apr; 32(13-14):292-4. PubMed ID: 13164237
    [No Abstract]   [Full Text] [Related]  

  • 15. [Identification of hemolytic streptococci in scarlet fever].
    HANDLOSER M
    Arch Hyg Bakteriol; 1954 Sep; 138(5):322-31. PubMed ID: 13218599
    [No Abstract]   [Full Text] [Related]  

  • 16. Typing of hemolytic streptococci in scarlet fever and other streptococcal diseases.
    HEDLUND P; LAGERCRANTZ R
    Scand J Clin Lab Invest; 1953; 5(1):39-43. PubMed ID: 13064611
    [No Abstract]   [Full Text] [Related]  

  • 17. Mitogenic factors from group G streptococci associated with scarlet fever and streptococcal toxic shock syndrome.
    Assimacopoulos AP; Stoehr JA; Schlievert PM
    Adv Exp Med Biol; 1997; 418():109-14. PubMed ID: 9331611
    [No Abstract]   [Full Text] [Related]  

  • 18. Scarlet fever and types of erythrogenic toxins produced by the infecting streptococcal strains.
    Knöll H; Srámek J; Vrbová K; Gerlach D; Reichardt W; Köhler W
    Zentralbl Bakteriol; 1991 Dec; 276(1):94-106. PubMed ID: 1789905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decrease in tetracycline-resistant strains and changes in type distribution of Group A hemolytic streptococci recently isolated from patients with scarlet fever].
    Misuno K; Hirayama A; Yoshida R
    Kansenshogaku Zasshi; 1976 Feb; 50(2):33-7. PubMed ID: 820815
    [No Abstract]   [Full Text] [Related]  

  • 20. Group and type distribution of beta-haemolytic streptococci in scarlet fever, Belgrade, Yugoslavia, 1973-1982 (a note).
    Adanja B; Vlajinac H
    Acta Microbiol Hung; 1985; 32(2):193-5. PubMed ID: 3904307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.